Koers Chalice Brands Ltd. Canadian Securities Exchange
Aandelen
CHAL
CA15756R1047
Farmaceutische producten
Omzet 2019 | 15,75 mln. 21,54 mln. 14,73 mln. | Omzet 2020 | 21,91 mln. 29,95 mln. 20,48 mln. | Marktkapitalisatie | 20,07 mln. 27,44 mln. 18,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -46 mln. -62,88 mln. -43 mln. | Nettowinst (verlies) 2020 | -10 mln. -13,67 mln. -9,35 mln. | EV/omzet 2019 | 1,28 x |
Nettoschuld 2019 | 6,22 mln. 8,5 mln. 5,82 mln. | Nettoschuld 2020 | 10,27 mln. 14,04 mln. 9,6 mln. | EV/omzet 2020 | 1,38 x |
K/w-verhouding 2019 |
-0,23
x | K/w-verhouding 2020 |
-1,89
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 78,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,76% | 5,69 mld. | |
-32,34% | 3,53 mld. | |
-2,23% | 3,06 mld. | |
-25,26% | 2,62 mld. | |
-10,88% | 2,29 mld. | |
+40,09% | 1,86 mld. | |
+40,90% | 1,43 mld. | |
-15,16% | 1,41 mld. | |
+42,86% | 1,4 mld. |